Involvement of glial glutamate transporters in morphine dependence

Annals of the New York Academy of Sciences

Volumn 1025, Issue , 2004, Pages 383-388

  Nakagawa, Takayuki ^a   Satoh, Masamichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Drug addiction; Glia; GLT 1; Glutamate transporters; Morphine dependence

Indexed keywords

5 METHYL 1 NICOTINOYL 2 PYRAZOLINE; ASPARTIC ACID DERIVATIVE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; MORPHINE; NALOXONE; PYRAZOLINE DERIVATIVE; THREO BETA BENZYLOXYASPARTATE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; CORPUS STRIATUM; GENE EXPRESSION; GENE TRANSFER; GLIA CELL; LOCUS CERULEUS; MORPHINE ADDICTION; NEUROPROTECTION; NONHUMAN; NORTHERN BLOTTING; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PROTEIN EXPRESSION; THALAMUS;

EID: 10444276594     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1307.047     Document Type: Conference Paper

References (15)

1. BESPALOV, A., M. DUMPIS, L. PIOTROVSKY & E. ZVARTAU. 1994. Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine. Eur. J. Pharmacol. 264: 233-239.
2. BRISTOW, L.J., J.E. HOGG & P.H. HUTSON. 1997. Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats. Neuropharmacology 36: 241-250.
3. FUNDYTUS, M.E. & T.J. CODERRE. 1994. Morphine dependence is affected by activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors. Br. J. Pharmacol. 113: 1215-1220.
4. HIGGINS, G.A., P. NGUYEN & E.M. SELLERS. 1992. The NMDA antagonist dizocilpine (MK-801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal. Life Sci. 50: PL167-PL172.
5. KATAGIRI, H., K. TANAKA & T. MANABE. 2001. Requirement of appropriate glutamate concentrations in the synaptic cleft for hippocampal LTP induction. Eur. J. Neurosci. 14: 547-553.
6. MCLEMORE, G.L., B. KEST & C.E. INTURRISI. 1997. The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence. Brain Res. 778: 120-126.
7. NAKAGAWA, T., T. OZAWA, K. SHIGE, et al. 2001. Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator. Eur. J. Pharmacol. 419: 39-45.
8. OZAWA, T., T. NAKAGAWA, K. SHIGE, et al. 2001. Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal. Brain Res. 905: 254-258.
9. POPIK, P. & W. DANYSZ. 1997. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate antagonist, memantine. J. Pharmacol. Exp. Ther. 280: 854-865.
10. ROTHSTEIN, J.D., M. DYKES-HOBERG, C.A. PARDO, et al. 1996. Knockout of glutamate transporters reveals a major role for astroglial transport in excitatory and clearance of glutamate. Neuron 16: 675-686.
11. SEAL, R.P. & S.G. AMARA. 1999. Excitatory amino acid transporters: a family in flux. Annu. Rev. Pharmacol. Toxicol. 39: 431-456.
12. SHIMADA, F., Y. SHIGA, M. MORIKAWA, et al. 1999. The neuroprotective agent MS-153 stimulates glutamate uptake. Eur. J. Pharmacol. 386: 263-270.
13. SHIMAMOTO, K., B. LEBRUN, Y. YASUDA-KAMATANI, et al. 1998. DL-threo-β-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol. Pharmacol. 53: 195-201.
14. TRUJILLO, K.A. & H. AKIL. 1991. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251: 85-87.
15. UMEMURA, K., T. GEMBA, A. MIZUNO & M. NAKASHIMA. 1996. Inhibitory effect of MS-153 on elevated brain glutamate level induced by rat middle cerebral artery occlusion. Stroke 27: 1624-1628.